M&A activity in the medtech and orthopedic sectors has slowed to a decade-low in 2024, with only six orthopedic acquisitions compared to nearly 30 in 2023. Since 2021, M&A volume has dropped by 40%, largely due to many leading companies being in the midst of large acquisitions and integrations, which limits new deal-making.
Stryker, the largest orthopedic company, has made recent acquisitions, like Artelon, to strengthen its sports medicine and foot and ankle segments. Its purchase of Vertos Medical highlights a focus on interventional treatments and later-stage investments. Enovis has...
